SHL Telemedicine Announces Advancements in its Direct-to-Consumer Strategy in the US
These advancements in operations infrastructure are pivotal in laying the groundwork for the upcoming D2C offerings, which the company plans to initiate in the US already this year.
- These advancements in operations infrastructure are pivotal in laying the groundwork for the upcoming D2C offerings, which the company plans to initiate in the US already this year.
- Erez Nachtomy, CEO of SHL Telemedicine, expressed, "Advancing towards the launch of our D2C operations in the US reflects our commitment to bridging healthcare accessibility gaps.
- The SmartHeart® technology grants remote connectivity to a network of cardiologists, ensuring regulated and compliant ECG reviews across the US.
- The ongoing developments embody SHL Telemedicine’s relentless pursuit of delivering unparalleled value to its customers and stakeholders while championing the transformative power of telemedicine.